Phycocyanin and Potentially Antihyperglycemic Effects
Updated: Feb 26, 2020
There are about 25.8 million Americans living with some form of diabetes. The two main types are Type 1 and Type 2. Diabetes is a disease that occurs when your blood glucose is too high, which prevents your body from properly using the energy from the food you eat. In Type 1 diabetes, the pancreas makes little or no insulin, so sugar cannot get into the body's cells for use as energy. In Type 2 diabetes, the pancreas makes insulin, but it either doesn't produce enough, or the insulin does not work properly (clevelandclinic.org).
A study on the bioactive compound in spirulina showed it contains antihyperglycemic activity, or antidiabetes activity. Spirulina is one of the microalgae containing nutrients used as a functional food and nutraceutical. Results from a study at Bogor Agricultural University in Indonesia showed oral administration of biomass and phycocyanin of Spirulina fusiformis Voronikhin proved to decrease blood glucose levels.
Mice were fed the biomass containing Spirulina fusiformis Voronikhin and phycocyanin. A dose of 150 mg · kg–1 body weight can lower blood glucose levels up to 33 % of the control condition, thus, it can be used for diabetes mellitus therapy. Click the link below to read the full study.